Medical advice switch: Daily aspirin to prevent heart disease offers no benefits — and could be harmful

Credit: AARP
Credit: AARP

Taking low-dose aspirin every day to prevent a heart attack or stroke provides little to no benefit to people without cardiovascular disease but could instead increase the risk of dangerous bleeding, a new report from the U.S. Preventive Services Task Force says.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

In the last several years, new evidence from various clinical trials has “cast doubt over the use of ‘aspirin for all,’” said Carlos G. Santos-Gallego, a cardiologist at The Mount Sinai Hospital in New York City. Mounting evidence suggests that the higher a person’s risk of getting heart disease and the lower their risk of bleeding, the more they benefit from taking aspirin, he said. Bleeding risk, however, increases with age.

Those who benefit most from taking a daily low-dose aspirin tablet are people with greater than a 15% or 20% risk for developing cardiovascular disease over a 10-year period, according to the recommendation, published in JAMA.

To meet the 10% or greater risk threshold set by the task force, “you’ve got to have a lot of risk factors,” said cardiologist Steven Nissen, chief academic officer of the Heart, Vascular & Thoracic Institute at the Cleveland Clinic. “Not very many people, even with these recommendations, are going to qualify.”

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.